Related Experiment Video
Updated: Jan 31, 2026

Whole-cell Currents Induced by Puff Application of GABA in Brain Slices
Published on: October 12, 2017
Arginine Deiminase: Current Understanding and Applications
Mahboubeh Zarei1, Mohammad Reza Rahbar1, Mohammad Hossein Morowvat1,2
1Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Background:
Arginine deiminase (ADI), an arginine catabolizing enzyme, is considered as an anti-tumor agent for the treatment of arginine auxotrophic cancers. However, some obstacles limit its clinical applications.
Objective:
This review will summarize the clinical applications of ADI, from a brief history to its limitations, and will discuss the different ways to deal with the clinical limitations.
Method:
The structure analysis, cloning, expression, protein engineering and applications of arginine deiminase enzyme have been explained in this review.
Conclusion:
Recent patents on ADI are related to ADI engineering to increase its efficacy for clinical application. The intracellular delivery of ADI and combination therapy seem to be the future strategies in the treatment of arginine auxotrophic cancers. Applying ADIs with optimum features from different sources and or ADI engineering, are promising strategies to improve the clinical application of ADI.
Related Concept Videos
Understanding the Self
Understanding Self-Concept
Understanding Deception
Understanding Love
Understanding Consciousness
Sleep, a crucial state, is characterized by reduced...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...

